Looks like you clickedhttps://www.ema.europa.eu/en/news/first-antidote-reversal-anticoagulation-factor-xa-inhibitors-apixaban-rivaroxaban#:~:text=Andexanet%20alfa%2C%20the%20active%20substance,anticoagulant%20effect%20of%20these%20inhibitors
If you do not want to visit that page, you can close this browser tab.
